Navigation Links
FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
Date:1/22/2014

Bethesda, MD This FASEB Science Research Conference focuses on signaling pathway feedback loops, reprogramming and mechanisms of drug resistance due to signaling rewiring. A growing appreciation has emerged that though many of the core components of signaling pathways have been identified in the last three decades an in depth understanding of the dynamics, spatial constraints and contextual inputs needs to be elucidated.

The conference will focus on advances on the elaboration of signaling feedback loops underlying resistance in cancer as a model system. Highlights of the conference will include the structural elucidation of kinase regulation, analysis of crosstalk and complex signaling networks, scaffold proteins and kinase signal sensitization, kinases in stress response and nutrient sensing, the role of protein kinases, and their downstream targets regulating growth, adhesion, invasion, metastasis, the use of quantitative mass spectrometry and therapeutic kinase inhibitor strategies.

Travel grants and poster awards will be available for trainees. An impressive slate of world-renown speakers combined with the intimacy of a highly focused agenda with ample opportunities for discussion and interaction, are designed to enhance collaboration and foster new ideas and research directions in the field.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
2. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
3. FASEB announces BioArt image and video competition winners
4. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
5. MARC travel awards announced for the June 2013 FASEB science research conferences
6. New FASEB analysis documents impact of budget cuts on biomedical research
7. FASEB MARC Travel Awards announced for the 2013 American College of Sports Medicine Northwest Chapter Meeting
8. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
9. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
10. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
11. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2017)... 2017 IDTechEx Research, a leading provider of ... the availability of a new report, Sensors for Robotics: Technologies, ... Reading ... ... Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements ... Management (IAM) lifecycle is comprised of a comprehensive ... the purpose of maintaining digital identities and providing ... and applications. There are significant number of programs ... time to time by optimizing processes and changing ...
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 16, 2017  MDNA Life Sciences Inc. (MDNA), ... liquid biopsy tests based on the mitochondrial genome, ... license agreement with its first international commercial partner, ... test for prostate cancer, the Prostate Mitomic Test ... This is the first overseas appointment for MDNA ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... 16, 2017  Champions Oncology, Inc. (NASDAQ: ... sale of advanced technology solutions and products to personalize ... the addition of new cohorts of PDX models to ... will expand Champions, product line in hepatocellular cancer, breast ... AML, and non-small cell lung cancer (including EGFR mutation; ...
(Date:2/16/2017)... , Feb. 16, 2017 Paradigm Diagnostics ... B financing, adding an additional $3M from New Sciences ... Verde Venture Partners and other strategic partners at the ... further accelerating commercial adoption of their flagship Paradigm Cancer ... expanding the Paradigm cancer registry. Dr. ...
Breaking Biology Technology: